Latest News

The digital health fund, launched by Astellas Pharma and MPM Capital late last month, will initially look to invest up to $6m in two to three deals per year.

The State of Startup/Corporate Collaboration 2016 report suggests 67% of corporates prefer early interaction, with 82% saying interaction was at least somewhat important.

Turner's strategic investment as part of a $45m round for Refinery29 is part of an ongoing trend that likely spells the end for what we think of as 'old media'.

Marcin Hejka, who oversees Intel Capital's activity in Greater Europe and India, has spoken to GCV about the unit's strategic focus.

Uber has lost its battle in China, but as the largest shareholder in a $35bn company that is the overwhelming market leader it may yet win the war.

Global Fashion Group's latest funding makes it one of several Rocket entities to have raised cash this year, but they will need to stem losses before the money tap turns off.

A survey found a 16 percentage point rise in the number of Brazilian corporations investing in startups.

Pfizer has leapt to the top of the most active corporate venturing investors in US healthcare deals for the first half of 2016, as Novartis falls out of the top 10.

Second Genome, which is applying genomics technology to the microbiome, is the latest in a growing string of gene technology companies to raise substantial funding.

Oyo Rooms has raised $61.3m from existing investors likely to include SoftBank, as it looks to expand its branded budget hotel experience across India and into adjacent sectors.